Long-term Anticoagulation in a Patient With Severe Hemophilia A

by palligoelme@gmail.com | Jan 2, 2026 | Clinical Trials

​ Conditions: Hemophilia A Sponsors: University Hospital, Strasbourg, France Recruiting Conditions: Hemophilia A Sponsors: University Hospital, Strasbourg, France Recruiting 

Impact of Foot Reflexology on Nausea After Obesity Surgery

by palligoelme@gmail.com | Dec 31, 2025 | Clinical Trials

​ Conditions: Sleeve Gastrectomy Interventions: Other: Foot reflexology Sponsors: Centre Hospitalier Departemental Vendee Not yet recruiting Conditions: Sleeve Gastrectomy Interventions: Other: Foot reflexology Sponsors: Centre Hospitalier Departemental Vendee Not yet...

Phase 1 Parallel Study of CLR 125 in Triple Negative Breast Cancer

by palligoelme@gmail.com | Dec 31, 2025 | Clinical Trials

​ Conditions: Breast Cancer Interventions: Drug: Iopofosine I 131; Drug: CLR 125 Sponsors: Cellectar Biosciences, Inc. Recruiting Conditions: Breast Cancer Interventions: Drug: Iopofosine I 131; Drug: CLR 125 Sponsors: Cellectar Biosciences, Inc....

Clinical Lymphedema Evaluation – Advancing Reconstruction of Head and Neck Lymphatics With Symani

by palligoelme@gmail.com | Dec 31, 2025 | Clinical Trials

​ Conditions: Lymphedema; Lymphedema of Face; Internal Lymphedema; External Lymphedema; Lymphedema of Neck Interventions: Device: Symani Surgical System Sponsors: MMI (Medical Microinstruments, Inc.) Not yet recruiting Conditions: Lymphedema; Lymphedema of Face;...

Handheld MPI Imaging to Track Stem Cells in Osteoarthritis

by palligoelme@gmail.com | Dec 31, 2025 | Clinical Trials

​ Conditions: Knee Arthritis Osteoarthritis Interventions: Biological: Human Umbilical Cord-derived Mesenchymal Stromal Cells (hUC-MSCs); Other: Ferumoxytol (SPIO) Solution for Injection (Placebo) Sponsors: Soochow University Enrolling by invitation Conditions: Knee...

A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

by palligoelme@gmail.com | Dec 31, 2025 | Clinical Trials

​ Conditions: Healthy Participants Interventions: Drug: Andexanet alfa; Drug: Rivaroxaban; Drug: Apixaban; Drug: Enoxaparin; Other: Placebo Sponsors: AstraZeneca; Parexel Not yet recruiting Conditions: Healthy Participants Interventions: Drug: Andexanet alfa; Drug:...